Philip William Fowler

Philip William Fowler

Auto-generated profile, based on publicly available information

Philip William Fowler

Modernising Medical Microbiology Unit, Nuffield Department of Medicine, University of Oxford

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2010 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
SNSimon Newstead
Simon Newstead
DDDavid Drew
David Drew
ACAlexander Cameron
Alexander Cameron
Vincent L. G. PostisVincent L. G. Postis
Vincent L. G. Postis
XXXiaobing Xia
Xiaobing Xia
SISo Iwata
So Iwata
PepT1 and PepT2 are major facilitator superfamily (MFS) transporters that utilize a proton gradient to drive the uptake of di‐ and tri‐peptides in the small intestine and kidney, respectively. They are the major routes by which we absorb dietary nitrogen and many orally administered drugs. Here, we present the crystal structure of PepTSo, a functionally similar prokaryotic homologue of the mammalian peptide transporters from Shewanella oneidensis . This structure, refined using data up to 3.6 Å resolution, reveals a ligand‐bound occluded state for the MFS and provides new insights into a general transport mechanism. We have located the peptide‐binding site in a central hydrophilic cavity, which occludes a bound ligand from both sides of the membrane. Residues thought to be involved in proton coupling have also been identified near the extracellular gate of the cavity. Based on these findings and associated kinetic data, we propose that PepTSo represents a sound model system for understanding mammalian peptide transport as catalysed by PepT1 and PepT2. There is a [Have You Seen?][1] (July 2012) linked with this article. [1]: http://dx.doi.org/10.1038/emboj.2012.206

1 June 2012 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
NSNicolae Solcan
Nicolae Solcan
JKJane Kwok
Jane Kwok
PFPhilip W Fowler
Philip W Fowler
ACAlexander Cameron
Alexander Cameron
DDDavid Drew
David Drew
SNSimon Newstead
Simon Newstead
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

21 August 2020 in eLife
Verified
Journal Article
Open access
DEDavid W Eyre
David W Eyre
SLSheila F Lumley
Sheila F Lumley
DODenise O'Donnell
Denise O'Donnell
MCMark Campbell
Mark Campbell
ESElizabeth Sims
Elizabeth Sims
TWTimothy M Walker
Timothy M Walker
We conducted voluntary Covid-19 testing programmes for symptomatic and asymptomatic staff at a UK teaching hospital using naso-/oro-pharyngeal PCR testing and immunoassays for IgG antibodies. 1128/10,034 (11.2%) staff had evidence of Covid-19 at some time. Using questionnaire data provided on potential risk-factors, staff with a confirmed household contact were at greatest risk (adjusted odds ratio [aOR] 4.82 [95%CI 3.45–6.72]). Higher rates of Covid-19 were seen in staff working in Covid-19-facing areas (22.6% vs. 8.6% elsewhere) (aOR 2.47 [1.99–3.08]). Controlling for Covid-19-facing status, risks were heterogenous across the hospital, with higher rates in acute medicine (1.52 [1.07–2.16]) and sporadic outbreaks in areas with few or no Covid-19 patients. Covid-19 intensive care unit staff were relatively protected (0.44 [0.28–0.69]), likely by a bundle of PPE-related measures. Positive results were more likely in Black (1.66 [1.25–2.21]) and Asian (1.51 [1.28–1.77]) staff, independent of role or working location, and in porters and cleaners (2.06 [1.34–3.15]).

2 December 2019 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
MHMartin Hunt
Martin Hunt
PBPhelim Bradley
Phelim Bradley
Simon Grandjean LapierreSimon Grandjean Lapierre
Simon Grandjean Lapierre
SHSimon Heys
Simon Heys
MTMark Thomsit
Mark Thomsit
ZIZamin Iqbal
Zamin Iqbal
Two billion people are infected with Mycobacterium tuberculosis, leading to 10 million new cases of active tuberculosis and 1.5 million deaths annually. Universal access to drug susceptibility testing (DST) has become a World Health Organization priority. We previously developed a software tool, Mykrobe predictor, which provided offline species identification and drug resistance predictions for M. tuberculosis from whole genome sequencing (WGS) data. Performance was insufficient to support the use of WGS as an alternative to conventional phenotype-based DST, due to mutation catalogue limitations. Here we present a new tool, Mykrobe, which provides the same functionality based on a new software implementation. Improvements include i) an updated mutation catalogue giving greater sensitivity to detect pyrazinamide resistance, ii) support for user-defined resistance catalogues, iii) improved identification of non-tuberculous mycobacterial species, and iv) an updated statistical model for Oxford Nanopore Technologies sequencing data. Mykrobe is released under MIT license at https://github.com/mykrobe-tools/mykrobe. We incorporate mutation catalogues from the CRyPTIC consortium et al. (2018) and from Walker et al. (2015), and make improvements based on performance on an initial set of 3206 and an independent set of 5845 M. tuberculosis Illumina sequences. To give estimates of error rates, we use a prospectively collected dataset of 4362 M. tuberculosis isolates. Using culture based DST as the reference, we estimate Mykrobe to be 100%, 95%, 82%, 99% sensitive and 99%, 100%, 99%, 99% specific for rifampicin, isoniazid, pyrazinamide and ethambutol resistance prediction respectively. We benchmark against four other tools on 10207 (=5845+4362) samples, and also show that Mykrobe gives concordant results with nanopore data. We measure the ability of Mykrobe-based DST to guide personalized therapeutic regimen design in the context of complex drug susceptibility profiles, showing 94% concordance of implied regimen with that driven by phenotypic DST, higher than all other benchmarked tools.

26 August 2016 in Soft Matter
Verified
Journal Article
Open access
PDF file
PFPhilip W. Fowler
Philip W. Fowler
JHJean Hélie
Jean Hélie
ADAnna Duncan
Anna Duncan
MCMatthieu Chavent
Matthieu Chavent
HKHeidi Koldsø
Heidi Koldsø
MSMark Sansom
Mark Sansom
The ease with which a cell membrane can bend and deform is important for a wide range of biological functions. Peripheral proteins that induce curvature in membranes (e.g. BAR domains) have been studied for a number of years. Little is known, however, about the effect of integral membrane proteins on the stiffness of a membrane (characterised by the bending rigidity, Kc). We demonstrate by computer simulation that adding integral membrane proteins at physiological densities alters the stiffness of the membrane. First we establish that the coarse-grained MARTINI forcefield is able to accurately reproduce the bending rigidity of a small patch of 1500 phosphatidyl choline lipids by comparing the calculated value to both experiment and an atomistic simulation of the same system. This enables us to simulate the dynamics of large (ca. 50 000 lipids) patches of membrane using the MARTINI coarse-grained description. We find that altering the lipid composition changes the bending rigidity. Adding integral membrane proteins to lipid bilayers also changes the bending rigidity, whilst adding a simple peripheral membrane protein has no effect. Our results suggest that integral membrane proteins can have different effects, and in the case of the bacterial outer membrane protein, BtuB, the greater the density of protein, the larger the reduction in stiffness.

1 February 2015 in Structure
Verified
Journal Article
Open access
PFPhilip W. Fowler
Philip W. Fowler
MOMarcella Orwick-Rydmark
Marcella Orwick-Rydmark
SRSebastian Radestock
Sebastian Radestock
NSNicolae Solcan
Nicolae Solcan
PDPatricia M. Dijkman
Patricia M. Dijkman
SNSimon Newstead
Simon Newstead
Proton-coupled oligopeptide transporters belong to the major facilitator superfamily (MFS) of membrane transporters. Recent crystal structures suggest the MFS fold facilitates transport through rearrangement of their two six-helix bundles around a central ligand binding site; how this is achieved, however, is poorly understood. Using modeling, molecular dynamics, crystallography, functional assays, and site-directed spin labeling combined with double electron-electron resonance (DEER) spectroscopy, we present a detailed study of the transport dynamics of two bacterial oligopeptide transporters, PepTSo and PepTSt. Our results identify several salt bridges that stabilize outward-facing conformations and we show that, for all the current structures of MFS transporters, the first two helices of each of the four inverted-topology repeat units form half of either the periplasmic or cytoplasmic gate and that these function cooperatively in a scissor-like motion to control access to the peptide binding site during transport.